Thank you for your interest in Dignity Health Heart and Vascular Institute of Greater Sacramento's 31st Annual Cardiology & Electrophysiology CE Symposium 2022. 

Event Details 

Saturday, September 10, 2022
7:30 a.m. to 3:10 p.m.
Hyatt Regency Sacramento
1209 L St
Sacramento, CA 95814

REGISTRATION NOW OPEN!

7:30 a.m. Exhibitors     
8:00 a.m. Welcome 
3:10 p.m. Closing Remarks/Adjourn

An Update on Hypertension and the Recent Guidelines
Prakash Deedwania, MD, FACC, FAHA, FESC

Device Therapy of Chronic Heart Failure
Barry Greenberg, MD, FACC, FAHA, FHFSA

Comprehensive Cardiovascular Risk Reduction in Diabetes: The Role of Newer Drugs
Prakash Deedwania, MD, FACC, FAHA, FESC

Medical Therapy of Chronic Heart Failure
Barry Greenberg, MD, FACC, FAHA, FHFSA

Aortic Valve Stenosis
Kapil Sharma, MD, MBA

Cardiovascular Disease and Cancer - What Cardiologists Should Know
Annabelle Santos Volgman, MD, FACC, FAHA

Mitral and Tricuspid Valve Disease
Kapil Sharma, MD, MBA

Prevention of Heart Disease in Women 
Annabelle Santos Volgman, MD, FACC, FAHA

Catheter Ablation for Atrial Fibrillation: State-of-the-Art, Outcomes and Evolving Technologies 
Andre d'Avila, MD, PhD

Left Atrial Appendage Closure in Patients with Atrial Fibrillation for Stroke Prevention 
Shephal Doshi, MD, FACC

Catheter Ablation of Ventricular Tachycardia: An Overview for Clinicians and Future Perspectives
Andre d'Avila, MD, PhD

Panel Discussion 
Andre d'Avila, MD, PhD; Shephal Doshi, MD, FACC; Mark Bowers, MD; and Padraig O'Neill, MD, FACC, FHRS

At the conclusion of our program, participants should be able to implement the following changes to their professional practice:

• Describe various stages of hypertension, related complications, and the recent treatment guidelines.
• Recognize the role of device therapy in treating patients with heart failure, and identify appropriate patients.
• Identify the overall risk of cardiovascular disease in their diabetic patients and be able to incorporate the latest treatment modalities available.
• Identify guideline directed medical therapies for patients with heart failure, and recognize which patients should be considered as candidates for these drugs and be cognizant of the effect of each drug on the natural history of heart failure.
• Describe recent advances in transcatheter aortic valve replacement.
• Monitor patients for cardiovascular complications during cancer therapy.
• Appraise recent advances in transcatheter replacement therapies.
• Break down the sex differences in preventing cardiovascular disease in women and men.
• Identify new therapeutic options for patients with atrial fibrillation.
• Identify appropriate patients for left atrial appendage closure, and evaluate the risk/benefit profile for the procedure.
• Identify new therapeutic options for patients with ventricular tachycardia.

Scott B. Baron, MD, FACC, FSCAI
Symposium Chairman
Director, Cardiac Emergency Services
Dignity Health Mercy San Juan Medical Center

Clinical Professor of Medicine
California Northstate University School of Medicine

Arash Aryana, MD, PhD, FACC, FHRS
Symposium Co-Chairman
Director, Greater Sacramento Cardiovascular Service Line
Director, Cardiac Electrophysiology Laboratory
Mercy General Hospital
Dignity Health Heart and Vascular Institute

Nathanael White, MHA, BSN, RN
Division Director, Cardiovascular Service Line
Dignity Health - Northern California Division

Prakash Deedwania, MD, FACC, FAHA, FESC
Professor of Medicine
University of California, San Francisco
Fresno, California

Barry Greenberg, MD, FACC, FAHA, FHFSA
Distinguished Professor of Medicine
University of California, San Diego
San Diego, California

Kapil Sharma, MD, MBA
Director, Cardiac Surgery
Dignity Health Mercy General Hospital
Dignity Health Mercy San Juan Medical Center
Sacramento, CA

Annabelle Santos Volgman, MD, FACC, FAHA
McMullan-Eybel Endowed Chair for Excellence in Clinical Cardiology
Professor of Medicine, Rush College of Medicine
Medical Director, Rush Heart Center for Women
Vice Chief for Academic Affairs, Division of Cardiology
Governor, American College of Cardiology of Illinois
Immediate Past Chair of the American Heart Association Women in Cardiology
2020 Recipient of the Women's Day Red Dress Award
Rush University Medical Center
Chicago, Illinois

Andre d'Avila, MD PhD
Director, Cardiac Arrhythmia Service
The Harvard Thorndike Electrophysiology Institute
Beth Israel Deaconess Medical Center
Boston, Massachusetts

Shephal Doshi, MD, FACC
Executive Director
Heart and Vascular Institute
Providence St. John's Health Center
Santa Monica, CA

P. Geroid O'Neill, MD, FACC, FHRS
Cardiac Electrophysiology
Dignity Health, Mercy General Hospital
Sacramento, CA

Mark Bowers, MD
Vice Chair, Cardiology
Dignity Health, Mercy General Hospital
Sacramento, CA

Accreditation Statement:

In support of improving patient care, Dignity Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider Number: 4004043

Provider Designee/Verification: Monica Bourke, MSN, RN

This activity was planned by and for the healthcare team, and learners will receive 5.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Nurses - This program has been awarded 5.5 ANCC contact hours by Dignity Health. Nurses should claim only credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved for 5.5 contact hours by the California Board of Registered Nursing – Provider Number 17375

Physician Assistants - Dignity Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

 

 

Pharmacy - Dignity Health designates this knowledge-based activity for 5.5 ACPE credit. This is not a valid statement of credit. Credit for pharmacists and technicians will be uploaded into CPE Monitor and will be available within 60 days post activity pending submission of individual NABP (EPID) number and DOB (Mo/Day).